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INTRODUCTION 
 
Polyamines have been known for a long-time as the first 
one, spermine, was discovered over 330 years ago by 
microscopic observation of human semen [reviewed in 
1]. They have since been found in all eukaryotes and 
most prokaryotes.  Polyamines are polycations (Figure 
1) and thus one of their main features is to interact with 
negatively charged molecules, such as DNA, RNA or 
proteins.  Given  their  promiscuity  in  binding  other 
molecules, they are involved in many functions, mostly 
linked  with  cell  growth,  survival  and  proliferation. 
Three polyamines, putrescine, spermidine and spermine, 
are  part  of  the  very  tightly  regulated  polyamine 
metabolic  pathway.  Polyamines  are  the  subject  of 
intensive research in order to elucidate their functions 
and  involvement  in  physiology.  Polyamines  are 
important  players  in  plant  growth,  stress  and  disease 
resistance [2], but they are also involved in diseases [3], 
for  example  Alzheimer’s  or  infectious  diseases.  The 
main research area for the involvement of polyamines in 
diseases  is  cancer,  as  high  levels  of  polyamines  are 
observed  in  cancer  cells  [3].  More  recently,  we  have 
shown a causative role for polyamines in longevity [4].  
This  review  will  give  an  update  on  the  field  of 
polyamine  research  and  begin  with  their  metabolism 
and transport. Then we will discuss their involvement in 
aging, stress, diseases with a special section on cancer, 
and what is known of their mechanisms of action. We 
argue that only by gathering information from all the 
various disciplines studying polyamines can we draw an 
accurate  picture  of  their  effects  and  mechanisms  of 
action. 
 
Polyamine metabolism and transport 
 
The  regulation  of  polyamine  levels  is  achieved  by  a 
combination  of  synthesis,  catabolism  and  transport. 
Below  is  a  summary  of  these  different  processes. 
Polyamine metabolism is summarized in Figure 2. For 
further details, several excellent reviews and papers on 
this topic have been published and the reader is referred 
to them and the references therein [5-8]. 
 
Polyamine synthesis 
 
Three main sources for polyamines exist in organisms: 
Food intake, cellular synthesis, microbial synthesis in 
the gut.  
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arginine, ornithine and methionine. The first step in the 
pathway is the production of ornithine from arginine by 
the  mitochondrial  enzyme  arginase.  Ornithine  is  then 
decarboxylated  by  ornithine  decarboxylase  (ODC)  to 
produce putrescine. ODC expression is tightly regulated 
from  transcription  to  post-translational  modifications. 
ODC  antizyme  directly  inhibits  ODC  activity  and  is 
also  responsible  for  facilitating  ODC  degradation  by 
targeting  it  to  the  26S  proteasome.  In  parallel  to 
putrescine  production,  L-methionine  is  converted  into 
S-adenosyl-L-methionine  (AdoMet),  which  is  then 
decarboxylated by AdoMet decarboxylase (AdoMetDC) 
to  produce  decarboxylated  AdoMet  (DcAdoMet). 
DcAdoMet is then used as an aminopropyl group donor 
either to putrescine by spermidine synthase to produce 
spermidine,  or  to  spermidine  to  produce  spermine  by 
spermine synthase. 
 
Polyamine catabolism 
 
The higher polyamines spermidine and spermine can be 
converted  back  to  putrescine  (Figure  2).  The  rate-
limiting  enzyme  of  polyamine  catabolism  is  the 
cytosolic  spermidine/spermine  N
1-acetyltransferase 
(SSAT).  SSAT  acetylates  both  spermine  and 
spermidine.  Acetylated  spermine  and  spermidine  then 
move into the peroxisome where they are oxidized by 
polyamine  oxidase  (PAO).  By-products  of  this 
oxidation  include  hydrogen  peroxide  (H2O2)  and 
acetaminopropanal.  SSAT  is  absolutely  necessary  for 
the formation of putrescine from spermidine. Spermine 
can also be back-converted into spermidine by spermine 
oxidase (SMO) in the cytoplasm. In contrast with PAO, 
the preferred substrate of SMO is spermine itself and 
not its acetylated derivative, acetylspermine. 
 
Polyamine transport 
 
Polyamine  transport  plays  an  essential  role  in 
polyamine levels regulation. Polyamine transport is well 
characterized in the bacterium Escherichia coli and the 
yeast  Saccharomyces  cerevisiae.  Polyamine  transport 
complexes have also been studied in plants. 
 
E. coli has two polyamine uptake systems belonging to 
the  ABC  transporters  family.  One  system  is  a 
spermidine-preferential  system  and  the  second  one  a 
putrescine-specific  system.  Each  system  consists  of  4 
transporters:  PotA  to  D  for  spermidine  transport  and 
PotF  to  I  for  putrescine  transport.  If  any  of  the 
spermidine transporters is missing, spermidine uptake is 
abolished.  There  are  also  two  exporters  (PotE  and 
CadB), uptaking polyamines at neutral pH and excreting 
them  at  acidic  pH.  Finally,  a  spermidine  excretion 
protein, MdtII was recently identified [9]. 
 
S. cerevisiae polyamine transport is energy-dependent 
and  regulated  mainly  by  phosphorylation  and 
dephosphorylation. The proteins DUR3 and SAM3, and 
to a lesser extent GAP1 and AGP2, are responsible for 
polyamine  uptake  across  the  plasma  membrane. 
Putrescine  can  be  taken  into  the  vacuole  by  the  4-
aminobutyric acid transporter UGA4. TPO1 to 4 excrete 
polyamines at acidic pH (at which yeast cells usually 
grow) but uptake them into the yeast cell at pH 8. A 
polyamine  preferential  excretion  protein,  TPO5,  has 
been  identified  on  Golgi  and  post-Golgi  vesicles. 
Recently,  Teixeira  et  al.  [10]  showed  that  the  gene 
QDR3,  coding  for  a  plasma  membrane  drug:  H
+ 
antiporter,  is  involved  in  resistance  to  spermine  and 
spermidine,  but  not  putrescine  in  yeast.  Δqdr3  yeast 
cells  grew  less  when  plated  on  food  containing 
spermidine  or  spermine  at  high  concentrations.  They 
accumulated  more  spermidine,  suggesting  it  is  likely 
involved in polyamine excretion. 
 
 
 
In  mammals,  the  TATA-binding  associated  factor  7 
(TAF7)  rescues  the  lack  of  polyamine  transport  in 
methylglyoxal bis (guanylhydrazone) Resistant Chinese 
hamster  ovary  cells  [11].  Antizyme,  the  protein 
responsible  for  ODC  inhibition  and  degradation  also 
enhanced  polyamines  and  acetylpolyamines  excretion. 
Finally,  a  diamine  transporter  has  been  identified  in 
colon  epithelial  cells,  which  could  be  responsible  for 
putrescine  as  well  as  acetylated  polyamines  excretion 
[12]. Despite these studies and substantial research in 
this area, no polyamine transporter has been identified 
in mammals. Alternatively, it is thought that polyamine 
uptake in mammals could be performed by endocytosis. 
Still,  a  set  of  characteristics  that  any  polyamine 
transporter should fit has been defined and should help 
Figure 1: Putrescine, spermidine and spermine chemical 
structure. 
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mammals [13]. We have carried out a search for human 
homologues for the known polyamine transporters in E. 
coli  and  S.  cerevisiae  (Table  1  and  supplementary 
table). It would now be interesting to study the hits we 
found  and  assess  whether  some  of  them  can  really 
transport polyamines. 
 
Polyamines and aging 
 
Polyamine levels decrease with age in many organisms 
[reviewed  in  14],  albeit  polyamine-  and  tissue-
specifically.  For  instance,  Nishimura  et  al.  [15] 
measured polyamine levels in 14 different tissues in 3, 
10  and  26  week-old  female  mice  and  found  that 
spermidine levels decreased in 11 out of the 14 tissues. 
In contrast, spermine decreased only in skin, heart and 
muscles. Putrescine levels were very low in all tissues at 
all ages. Vivó et al. [16] reported a negative correlation 
between spermidine content and age in several areas of 
the basal ganglia in human brains and a similar trend for 
spermine. More varied age-related changes have been 
observed  when  more  brain  areas  were  studied  in  rats 
[17].  We  reported  a  decrease  with  age  of  spermidine 
content  in  yeast  [4].  The  concentrations  of  specific 
polyamines and molecular conjugates varied with stages 
of  growth  (seedlings,  saplings  and  mature  trees)  in 
Pinus radiata [18]. The same authors reported that the 
total polyamine level increased but no difference in free 
polyamines  was  observed  in  Prunus  persica.  Despite 
these correlative changes in polyamines with age, it is 
only  recently  that  the  causative  involvement  of 
polyamines in the aging process has been investigated. 
 
The study of the effects of polyamines on aging seems 
to be more advanced in plant biology, where they have 
been  identified  as  “juvenility”  factors  for  some  time. 
For instance, Serafini-Fracassini et al. [19] showed that 
spermine  treatment  delayed  senescence  in  excised 
flowers of Nicotiana tabacum. After 48 hours, 70% of 
the  flowers  were  still  at  the  stage  at  which  they  had 
been  cut  (anthesis  or  peak  bloom)  whereas  in  the 
controls, 50% were at an early senescence stage and the 
other  50%  senescent.  Spermine  delayed  DNA 
degradation  and  preserved  chlorophyll  content. 
Spermidine and putrescine also delayed senescence of 
excised flowers, but to a lesser extent than spermine. 
More recently, the same group [20] studied senescence 
in  Lactuca  sativa.  In  cut  leaves,  spermine  postponed 
chlorophyll loss, as observed in N. tabacum, probably 
via  chlorophyll  stabilization  by  a  higher 
transglutaminase  activity.  In  intact  plants,  the  same 
preservation of chlorophyll and higher transglutaminase 
activity  were  observed  after  spermine  spraying, 
especially in senescent plants. In contrast, the treatment 
did  not  affect  the  protein  content  decrease  observed 
with age. 
 
Transporters  Number  of  human 
homologues 
 
Saccharomyces cerevisiae 
QDR3, TPO4, TPO5 
TPO2, SAM3 
TPO3 
AGP2, DUR3 
TPO1, GAP1 
UGT4 
 
Escherichia coli 
PotB, PotC, PotH, PotI 
PotD, PotF 
CadB 
PotE 
PotA, PotG 
 
 
1 
2 
3 
5 
6 
19 
 
 
0 
1 
10 
12 
75+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transgenic  animal  models,  particularly  rodents,  have 
been designed to modulate the activity of the polyamine 
pathway. However, these models have rarely been used 
in  the  context  of  studying  aging.  Suppola  et  al.  [21] 
reported the creation of a mouse model overexpressing 
Table  1:  Number  of  human  homologues  for  the 
Escherichia  coli  and  Saccharomyces  cerevisiae 
polyamine  transporters.  The  amino  acid  sequences  were 
retrieved from the NCBI protein database or the SGD database 
for  polyamine  transporters  of  Escherichia  coli  and 
Saccharomyces  cerevisiae  and  subjected  to  a  standard  blast 
search in NCBI (algorithm blastp). The chosen query database 
was  “RefSeq  Protein”.  The  search  was  restricted  to  Homo 
sapiens.  For  CadB  (E.  coli)  two  possible  sequences  were 
retrieved (147 and 444 amino acids) and both were used in our 
search. The shorter protein is part of the longer one. For MdtII 
no protein but rather a chain A and a chain B of the Mdt protein 
were  found.  Both  chains  were  used  in  our  search.  For  all 
transporters, only the homologues with an E value below 10
-4 
were included. Applying these parameters, the list of proteins 
yielded in this search was big. The results can be subdivided into 
3 groups: (i) those proteins without any apparent homolog; (ii) 
proteins with 1-6 homologs and (iii) proteins with a long list of 
homologs. While the result for group (i) is clear, the results for 
group (ii) are all at the edge of the applied threshold and none 
of them is an overwhelming hit. As for group (iii) the long list 
might be due to the homology of a conserved functional domain 
and to the inclusion of all isoforms of a specific  hit (see e.g. 
homologues for PotA in E. coli). The full list of homologues can 
be found in the Supplementary Table. 
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both  ODC  and  SSAT  under  the  methallothionein  I 
promoter.  These  mice  accumulated  high  levels  of 
putrescine  and  exhibited  a  depletion  of  spermine  and 
spermidine.  They  showed  no  overt  organ-specific 
histopathological  changes,  but  permanently  lost  their 
hair at 8 to 9 weeks of age. This hair loss was already 
observed  in  single  transgenics  for  SSAT 
overexpression,  which  also  exhibited  extensive 
wrinkling  upon  aging.  Finally,  the  double  transgenic 
mice were very short-lived. Cerrada-Gimenez et al. [22] 
also  reported  a  decreased  life  span  in  mice 
overexpressing SSAT. They noticed that in these mice, 
p53 expression in the liver was increased and that the 
SSAT  overexpressing  mice  exhibited  similar  aging 
phenotypes  to  mice  with  activated  p53  expression. 
However,  it  is  difficult  to  really  know  if  such 
phenotypes reflect an acceleration of the aging process 
or  whether  they  reflect  a  general  disturbance  of  the 
organism physiology leading to general weakness. 
 
Another strategy to study the effects of polyamines in 
aging  is  an  exogenous  administration  to  organisms. 
When polyamines are provided with food or water, their 
endogenous  levels  increase.  For  instance,  Soda  et  al. 
[23] observed an increase in spermine after 26 weeks in 
mice  and  after  two  months  in  humans  under  a  high-
polyamine  diet.  We  also  reported  [4]  that  providing 
spermidine in food or water increased its endogenous 
levels  in  yeast,  flies,  and  mouse  liver.  This  is  thus  a 
promising strategy, particularly valuable in the context 
of extending polyamine use to humans. Using such an 
experimental  approach  to  modulate  polyamine  levels, 
Soda et al. [24] fed male mice a low, normal or high-
polyamine chow. They showed that mortality in mice 
fed a high-polyamine chow was lower in the first 88 
weeks.  Unfortunately,  the  mice  were  sacrificed  at  88 
weeks of age, precluding the gathering of mortality data 
after  that  age.  The  authors  also  reported  a  lower 
incidence of age-related kidney glomerular atrophy kept 
on high-polyamine diet. Finally, they observed that old 
mice on high-polyamine chow kept a thicker coat with 
age and appeared more active. However, these last two 
observations were only qualitative as coat thickness and 
activity were not measured. The lower mortality in mice 
fed  a  high-polyamine  chow  was  not  due  to  a  dietary 
restriction effect as these mice ate more than the other 
two groups and exhibited similar body mass measured 
between  11  and  55  weeks  of  age.  These  results  are 
promising  and  further  studies  in  rodents  are  urgently 
required. 
 
We  have  recently  published  a  study  following  the 
consequences of external spermidine administration in 
various model organisms, including yeast, worms, flies, 
Figure  2:  Polyamine  metabolism.  Green:  biosynthesis;  blue:  catabolism;  red:  inhibitory  protein; 
black: eIF5A synthesis from spermidine. 
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mice  and  human  cells  [4].  Spermidine  increased 
chronological  life  span  in  wild-type  yeast  as  well  as 
remaining  replicative  life  span  in  old  yeast  cells.  In 
contrast,  a  Δspe1  yeast  mutant  unable  to  synthesize 
polyamines  was  short-lived.  This  decreased  life  span 
was  rescued  by  spermidine  as  well  as  by  putrescine 
addition.  We  also  showed  that  spermidine 
supplementation  increased  life  span  in  the  nematode 
worm  Caenorhabditis  elegans  by  15%  and  in  the  fly 
Drosophila melanogaster by up to 30%. At the cellular 
level,  spermidine  increased  survival  of  human 
peripheral blood mononuclear cells after 2 days from 
15% in the controls to 50% by preventing death from 
necrosis. These results strongly suggest that spermidine 
could  represent  a  new  preventive  agent  in  our  fight 
against  aging.  However,  so  far  research  has  mainly 
focused  on  the  effect  of  spermidine  on  life  span  and 
now it is important to study its effect, as well as the 
potential effects of other polyamines, on aging per se 
and quality of life (healthspan). 
 
Polyamines and stress 
 
Organisms  are  regularly  exposed  to  stress  and  the 
ability  to  resist  stress  is  a  part  of  survival  strategies. 
Various studies showed that polyamines had important 
roles in and generally correlate with stress resistance. 
Again, plant biology has been at the forefront of this 
research  area.  Readers  are  particularly  refereed  to  a 
recently published excellent review on the subject [2].  
Polyamines  are  particularly  important  for  adaptation 
and  resistance  to  cold  stress  [reviewed  in  25]  and 
polyamine levels increase in plants during abiotic stress 
such as salinity, extreme temperature, paraquat or heavy 
metals.  This  regulation  of  polyamines  under  stress  is 
achieved  by  differential  expression  of  polyamine 
Figure 3: Summary of the cellular mechanisms of action of polyamines. Upon entering the cell, 
polyamines exhibit various functions in the cytoplasm, nucleus and mitochondria. Polyamines are involved 
in the regulation of cell death and cell proliferation as well as in protein synthesis at the level of both gene 
expression and translation. Recent evidence also assigned polyamines functions in cell reprogramming and 
autophagy regulation. Thus, polyamines are involved in a broad array of processes and cellular responses 
that  suggest  a  complex  and  important  role  in  the  control  of  cellular  life  and  death.  PT:  permeability 
transition; Δψm: mitochondrial membrane potential. 
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spermidine  and  spermine  synthase  or  AdoMetDC. 
Exogenous application of polyamines led to, in varying 
degrees,  preserved  membrane  integrity  and  lower 
growth  inhibition  during  stress,  reduced  accumulation 
of ROS and increased activity of antioxidant enzymes 
such  as  catalase.  In  contrast,  polyamine  synthesis 
inhibitors  triggered  decreased  stress  resistance,  a 
phenotype counteracted by the simultaneous treatment 
with polyamines. Mutants in arginine decarboxylase or 
spermine synthase are sensitive to stress. Using another 
approach  to  study  the  role  of  polyamines  in  stress 
resistance,  many  groups  have  engineered  plants  to 
overexpress  polyamine  biosynthesis  genes,  especially 
arginine and ornithine decarboxylases and AdoMetDC. 
Many  studies  are  described  in  [2]  and  only  a  few, 
published later are reported here. Mohapatra et al. [26] 
studied aluminum stress in interaction with calcium in 
poplar  cell  cultures  with  normal  or  high  levels  of 
putrescine.  Reducing  or  increasing  the  amount  of 
calcium  had  no  effect  on  growth  in  the  control  cells 
except  when  drastically  reduced,  but  respectively 
decreased and increased growth in cells with high levels 
of putrescine. The addition of aluminum with normal or 
low calcium again had no effect in the control cells. In 
contrast, the cells with high putrescine content exhibited 
a better growth. These latter had a lower mitochondrial 
activity  than control cells, but a higher mitochondrial 
activity after 48 hours of exposure to aluminum. Taken 
together, these results suggest that in these cells, a high 
putrescine content is a disadvantage in a low-calcium 
environment  but  an  advantage  in  the  presence  of 
aluminum.  Wang  et  al.  [27]  cloned  the  arginine 
decarboxylase gene from trifoliate orange and carried 
out its functional study in transgenic Arabidopsis. The 
transgenic plants had higher levels of putrescine but not 
of  spermidine  and  spermine.  They  displayed  a  lower 
stomatal  density,  longer  roots,  larger  cell  size  and 
higher relative water content than the controls both in 
normal  conditions  and  under  stress.  They  had  similar 
germination  to  the  controls  in  normal  conditions  and 
germinated  better  under  osmotic  stress.  During 
dehydration, the transgenic plants lost less water, had a 
better  electrolyte  leakage  and  leaf  turgor.  Upon 
sustained  dehydration,  they  exhibited  better  growth, 
survival and electrolyte leakage. The transgenic plants 
were  also  more  resistant  to  cold.  This  higher  stress 
resistance might be due to lower accumulation of H2O2, 
O2
-  and  lipid  peroxidation.  Finally,  A.  thaliana 
overexpressing  spermine  synthase  or  wild-type 
exogenously supplied with spermine were shown to be 
more  resistant  to  infection  with  Pseudomonas 
viridiflava.  In  contrast,  mutants  in  spermine  synthase 
with low levels of spermine were less resistant to the 
same infection [28].  
 
In model organisms, the effect of polyamines on stress 
resistance  has  not  been  so  widely  studied,  but  as  in 
plants, has shown various results. SSAT overexpressing 
mice exhibited an increased production of H2O2 from 
polyamine degradation, a higher carbonyl content, and a 
decreased  expression of  superoxide  dismutase  (SOD), 
catalase and CYP450 2E1, suggesting these mice may 
be more prone to stress [22]. However, these mice were 
more resistant to thioacetamide or carbon tetrachloride, 
because  these  compounds  need  to  be  metabolized 
before becoming toxic, and were not metabolized to the 
same degree in the transgenic mice. Kaasinen et al. [29] 
had  earlier  shown  that  SSAT  overexpressing  mice 
exhibited decreased spontaneous activity, climbing and 
wheel running behavior. The transgenic mice were more 
phlegmatic  and  less  aggressive.  They  had  increased 
levels  of  ACTH  and  corticosterone,  and  decreased 
levels of TSH and T4, again suggesting they may be 
more prone to the effects of some stress. 
 
Putrescine, spermidine and spermine decreased survival 
under hypoxia in D. melanogaster [30]. In contrast, we 
have  shown  [4]  that  spermidine  treatment  increased 
resistance to heat and H2O2 in yeast. It also decreased 
age-related  oxidative  stress  in  mice  as  measured  by 
higher levels of free thiol groups. Markers of oxidative 
stress were also reduced in yeast. From these studies, 
we can conclude that polyamines are involved in stress 
resistance but in a much more complex way than just 
allowing  a  general  higher  resistance  to  stress  when 
present at higher levels. 
 
Polyamines and diseases 
 
Many diseases are associated with cellular dysfunction, 
such  as  aggregation  of  insoluble  compounds, 
uncontrolled cell death, and anarchic cell proliferation 
as in cancers. As regulators of cell growth and death, it 
is  likely  that  polyamines  may  affect  the  severity  and 
process of diseases. Polyamine levels increase in many 
diseases [see Table 2 in 3]. As polyamines also regulate 
growth  in  pathogens,  they  may  have  an  impact  on 
infectious and parasitic diseases as well. However, as 
for  aging  and  stress  resistance,  polyamines  have 
different  effects  in  different  models  and  on  different 
diseases.  We  will  review  here  some  of  the  results, 
focusing  on  age-related  diseases  and  infection.  The 
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reviewed in the next section. 
 
Vivó et al. [16] reported negative correlations between 
age and spermidine in several areas of the basal ganglia 
in  human  brain,  but  found  no  difference  between 
controls and Parkinson’s disease, Huntington’s disease 
and  progressive  supranuclear  palsy  patient’s  brains. 
More than 90% of circulating spermidine and over 70% 
of spermine are associated with red blood cells. Gomes-
Trolin  et  al.  [31]  observed  that  in  red  blood  cells, 
putrescine levels decreased in Parkinson’s disease and 
amyotrophic  lateral  sclerosis  patients.  In  contrast, 
spermidine  and  spermine  increased  in  both  sets  of 
patients.  There  was  no  correlation  between  the  levels 
measured and the severity of the disease. Earlier, Yatin 
et  al.  [32]  suggested  a  possible  involvement  of 
polyamine  metabolism  in  Alzheimer’s  disease.  They 
incubated rat embryonic hippocampal neuronal cultures 
with Aβ(1-42) or Aβ (25-35) peptides and/or vitamin E. 
They observed that both peptides induced cell death and 
that  this  was  largely  prevented  by  the  addition  of 
vitamin  E.  They  also  reported  an  increased  of 
polyamine  uptake  and  ODC  activity,  again  largely 
prevented by vitamin E, except for ODC activity with 
Aβ (25-35) peptides that was still significantly higher. 
Based on these results, the authors suggested that the 
changes  observed  were  a  response  of  polyamine 
metabolism to peptide-associated free radical damage. 
However,  whether  these  changes  reflected  a 
homeostatic  defense  mechanism  or  played  a  role  in 
neurotoxicity is still a matter of debate. In vitro studies 
have  shown  that  polyamines  can  alter  aggregation  of 
insoluble  compounds  associated  with  disease.  For 
instance,  Antony  et  al.  [33]  observed  that  all  three 
polyamines  increased  α-synuclein  aggregation  (that 
leads to the formation of Lewy bodies in Parkinson’s 
disease)  in  solution.  This  was  also  observed  more 
recently by Grabenauer et al. [34], who reported that 
spermine increased wild-type and mutants α-synuclein 
aggregation  in  solution  by  inducing  a  collapsed 
conformation. However, such results are not surprising 
since  polyamines  will  interact  and  bind  with  such 
molecules,  stabilizing  them  into  aggregates  when  in 
solutions. Studies looking at the effect of polyamines on 
the aggregation of such compounds in vivo are needed. 
Recently,  Lewandowski  et  al.  [35]  investigated  the 
involvement  of  polyamines  in  Parkinson’s  disease. 
They  found  that  spermine  was  more  toxic  to  yeast 
expressing  wild-type  or  mutant  α-synuclein. 
Overexpression  of  a  polyamine  transporter,  Tpo4, 
increased  α-synuclein  toxicity.  They  also  observed  in 
transgenic  mice  expressing  wild-type  human  α-
synuclein that neuronal accumulation of α-synuclein in 
the  substantia  nigra  was  increased  by  Berenil  (that 
decreases  SSAT  activity,  thus  polyamine  catabolism) 
and  decreased  by  DENSPM  (that  increases  SSAT 
activity).  However,  as  with  many  similar  studies,  the 
authors were cautious in pointing out that this type of 
correlative  observation  cannot  establish  a  pathogenic 
link with the disease. At the current stage of research, it 
cannot  be  ruled  out  that  the  changes  observed  in 
polyamine  levels  and  the  effects  of  polyamines  on 
disease  may  actually  be  a  compensatory,  protective 
mechanism.  Furthermore,  different  polyamines  have 
different  effects  on  disease.  For  instance,  spermine 
exacerbated ischemic neuronal injury in rodent models 
of ischemia [36]. This effect of spermine was dependent 
on  functional  acid-sensing  ion  channels  (ASICs), 
especially ASIC1a. However, no such damaging effect 
was observed with putrescine or spermidine. Spermine 
also  increased  neuronal  damage  in  culture  rat 
hippocampal neurons induced by oxygen and glucose 
deprivation.  DFMO,  an  ODC  inhibitor,  attenuated 
neuronal damage in these cells. In contrast, polyamines 
can  also  be  neuroprotective.  In  a  Xenopus  tadpole 
model  of  epilepsy,  Bell  et  al.  [37]  observed  that 
tadpoles  primed  with  a  first  seizure  induced  by 
pentylenetetrazole  (PTZ),  a  convulsant,  exhibited  a 
delayed onset of seizure upon a second exposure to PTZ 
as long as the period between both exposures was not 
too short (allowing recovery from first seizure). If the 
tadpoles  were  previously  given  DFMO,  an  ODC 
inhibitor,  onset  time  decreased,  showing  a  harmful 
effect  of  polyamine  depletion.  If  the  synthesis  of 
spermidine  and  spermine  (but  not  putrescine)  was 
blocked, the primed tadpoles still had a beneficial effect 
of  the  priming,  showing  that  the  beneficial  effect  of 
priming is triggered by putrescine and not the higher 
polyamines. If tadpoles were incubated with putrescine 
before exposure to PTZ, again the seizure onset time 
was  delayed.  No  such  effect  was  observed  when 
incubated with spermine, confirming the results using 
inhibitors  of  polyamine  synthesis.  They  showed  that 
neuroprotection  was  achieved  by  the  conversion  of 
putrescine into GABA, as a diamine oxidase (enzyme 
involved in the conversion of putrescine into GABA) 
inhibitor decreased seizure onset time. In an excellent 
review  of  transgenic  rodents  for  genes  of  polyamine 
metabolism, Jänne et al. [6] reported that accumulation 
of putrescine in the brain can be neuroprotective too. 
Transgenic mice and rats overexpressing ODC and thus 
exhibiting high levels of putrescine, particularly in the 
brain and testis, showed an elevated seizure threshold, 
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developed more slowly with smaller infarct volumes. 
 
Polyamines  are  also  important  in  diseases  such  as 
pancreatitis.  The  pancreas  is  the  organ  where  the 
highest levels of spermidine are observed in mammals. 
Transgenic  rats  overexpressing  SSAT  exhibited  a 
depletion  of  spermidine  and  spermine  and  developed 
pancreatitis.  Furthermore,  these  rats  failed  to  initiate 
liver  regeneration  after  partial  hepatectomy.  Liver 
regeneration  could  only  begin  once  the  spermidine 
levels  were  restored  because  of  ODC  activation. 
Supporting  the  involvement  of  polyamines  in  liver 
regeneration, Jung et al. [38] showed that methionine, 
ornithine,  AdoMet,  putrescine  and  spermidine  levels 
were  quickly  upregulated  in  rats  subjected  to  partial 
hepatectomy until the original liver weight was reached. 
Spermine  levels  were  decreased  because  of  the 
increased use of DcAdoMet for spermidine synthesis. 
 
Many  diseases  are  associated  with  inflammation  and 
polyamines  have  been  involved  in  inflammatory 
responses.  Polyamine  levels  generally  increase  with 
inflammation. However, whether they are pro- or anti-
inflammatory is still unclear. Recently, Puntambekar et 
al.  [39]  studied  the  dependence  on  polyamines  of 
inflammation  triggered  by  lipopolysaccharides  (LPS). 
In microglia in culture, the treatment with LPS+/- IFNγ 
increased  ODC,  SSAT  and  antizyme  activities,  both 
synthesis  and  catabolism  of  polyamines.  Intracerebral 
injection  only  increased  ODC  activity.  This  higher 
activity  led  to  the  influx  of  pro-inflammatory 
macrophages  into  the  CNS.  This  recruitment  was 
mediated  by  the  induction  of  CCL2,  a  macrophage 
chemoattractant.  Co-injection  of  DFMO,  an  ODC 
inhibitor,  prevented  CCL2  expression  by  LPS. 
Putrescine  and  spermine  induced  the  accumulation  of 
TNF (tumor necrosis factor) and CCL2 in mixed glial 
cultures. Spermidine did not have such an effect. The 
authors  concluded  that ODC  expression  was  an  early 
response  to  inflammation  and  that  the  increased 
polyamine levels resulting from ODC activation could 
lead to pro- or anti-inflammatory roles depending on the 
microenvironment. The potential anti-inflammatory role 
of  polyamines,  which  also  lead  to  the  production  of 
nitric  oxide,  has  led  Soda  [40]  to  hypothesize  that 
polyamine  uptake  may  help  with  cardiovascular 
diseases.  Recently,  spermidine  was  shown  to  be 
beneficial  against  two  age-related  diseases:  cataract 
formation  and  multiple  sclerosis.  Lentini  et  al.  [41] 
demonstrated that exogenous spermidine addition in the 
medium  delayed  the  progression  of  eye  lens 
opacification  in  an  in  vitro  cataract  model.  This  was 
achieved by interfering with transglutaminase activity. 
Finally, a spermidine-treated mouse model for multiple 
sclerosis (myelin oligodendrocyte glycoprotein-induced 
experimental  autoimmune  encephalomyelitis  mice) 
exhibited improved demyelination and axon survival in 
spinal cord and optic nerve, improved visual functions, 
and reduced H2O2-induced apoptosis in retinal ganglion 
cells  [42].  To  conclude,  polyamines  have  a  complex 
relationship  with  diseases.  They  may  be  harmful, 
neutral  or  beneficial,  depending  on  the  specific 
polyamine  and  disease.  However,  it  seems  that 
spermidine  showed  the  most  positive  effects,  which 
would be in line with its beneficial effects reported on 
life span and stress. 
 
Cell  proliferation  is  an  important  part  of  infection, 
whether it is multiplication of the pathogen into the host 
or  the  host  mounting  an  immune  response.  By 
controlling  cell  growth  and  proliferation,  polyamines 
may thus affect the outcome of infectious and parasitic 
diseases.  Again,  there  is  a  fine  balance  between 
beneficial  and  deleterious  effects  as  polyamines  may 
increase or decrease the fitness of both pathogen and 
host.  A  few  recent  studies  will  exemplify  this 
complexity. Nishimura et al. [43] reported that rats fed a 
polyamine-deficient chow survived longer an infection 
by Trypanosoma brucei brucei and were less anemic. 
This was not achieved by a reduction in the number of 
parasites,  but  probably  by  changes  in  cytokines  and 
nitric  oxide  production,  which  might  lessen  the 
symptoms of infection but not the parasite proliferation. 
In  contrast,  the  authors  reported  that  a  polyamine-
deficient  diet  restrained  the  proliferation  of 
Trypanosoma  brucei  gambiense.  Reyes-Becerril  et  al. 
[44]  studied  the  effect  of  putrescine,  spermidine  and 
spermine  on  seabream  head-kidney  leucocytes.  The 
polyamines  had  no  effect  on  peroxidase  content. 
Putrescine  increased  respiratory  burst  activity  after  4 
hours  and  spermidine  decreased  it.  Putrescine  also 
increased the percentage of phagocytic cells after 2 and 
4  hours  but  not  their  phagocytic  activity.  Finally, 
several genes important for the immune response were 
transcriptionally up-regulated by polyamines, although 
in a polyamine- and incubation time- specific manner. 
Taken  together,  these  results  suggest  that  polyamines 
can  help  develop  an  appropriate  adaptive  immune 
response.  
 
In plants too, polyamines have been shown to play a 
role  in  diseases  [reviewed  in  2].  Spermine  elicits  a 
defense  response  to  fungal  and  viral  pathogens. 
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spermine had an increased resistance to tobacco mosaic 
virus  [45].  However,  although  polyamines  can  be 
beneficial against infection, they can also be used by the 
pathogen to help proliferation.  
 
Pneumococci have a membrane polyamine transporter 
and some polyamine synthesis enzymes. Shah et al. [46] 
showed  that  mutant  strains  with  deficient  polyamine 
transport or synthesis were attenuated. They were less 
able  to  colonize  the  nasopharynx  and  cleared  more 
rapidly. Mice infected with mutant strains, except the 
mutant for lysine decarboxylase, survived the infection 
longer  than  when  infected  with  a  control  strain. 
However,  the  mutants  showed  no  defect  in  growth, 
survival  to  paraquat  or  low  pH  and  no  difference  in 
protein expression pattern. 
 
The special case of cancer 
 
Cancer  and  proliferative  cells  exhibit  high  levels  of 
polyamines [see Table 3 in 3] and this is thought to be a 
feature  by  which  cancer  cells  maintain  their 
proliferative  capacity.  However,  the  exact  role  of 
polyamines in cancer is still unclear. Forced induction 
of  ODC  activity  in  normal  cells  did  not  trigger 
oncogenic  transformation  [e.g.,  47]  although  some 
authors  [e.g.,  48]  reported  opposite  results  using  the 
same cells but different transfection vectors and ODC 
gene (murine versus human). At the level of the whole 
organism,  Alhonen  et  al.  [49]  could  not  observe  a 
higher  level  of  spontaneous  tumor  incidence  in 
transgenic mice overexpressing human ODC under its 
own promoter. Soda et al. [24] reported no increase in 
oncogenic  transformation  in  healthy  mice  fed  a  high 
polyamine diet. Given the lack of conclusive evidence 
that  polyamines  by  themselves  can  induce 
tumorigenesis,  studies  are  carried  out  either  in  model 
organisms tumor-prone or after induced tumorigenesis. 
A strategy to study the involvement of polyamines in 
cancer has been to use polyamine biosynthesis pathway 
inhibitors  or  polyamine  analogues.  For  instance, 
Bernacki  et  al.  [50]  used  DENSPM,  a  spermine 
analogue,  in  cell  culture  or  in  mice  to  study  tumor 
development. The proliferative activity of six different 
solid  tumor  cell  lines  decreased  after  the  treatment. 
DENSPM also delayed tumor growth in vivo but led to 
weight loss and toxicity at high doses. DENSPM did not 
alter ODC and AdoMetDC activities but depleted the 
polyamine  pool,  especially  spermidine  and  spermine. 
More recently, Kramer et al. [51] studied the effects of 
two  inhibitors,  DMFO  (ODC  inhibitor)  and  MDL-
73811 (AdoMetDC inhibitor) on cell cycle arrest. Each 
inhibitor  triggered  a  slight  decrease  in  cell  growth  in 
MALME-3M cells. In contrast, the combination of both 
inhibitors  led  to  a  rapid  cell  cycle  arrest,  with  an 
accumulation of cells in G1 and a reduction in S phase. 
This cell cycle arrest was reversible if not prolonged. 
They noted a strong p21 induction, a decrease in Rb 
phosphorylation  followed  by  a  decrease  in  total  Rb 
level.  These  changes  were  prevented  by  addition  of 
spermidine.  They  concluded  that  polyamine  depletion 
conferred phenotypes resembling cell senescence.  
 
This  is  in  agreement  with  the  observation  that 
polyamine  synthesis  decreases  in  senescent  cells. 
Transgenic rodents have been used to study the effect of 
polyamine  pathway  modulations  on  cancer  and  have 
yielded  a  wealth  of  data,  albeit  inconclusive  and 
sometime  contradictory  at  the  moment.  A 
comprehensive  overview  of  the  results  obtained  in 
rodents  transgenic  for  polyamine  pathway  genes  has 
been published [6]. We will here briefly summarize the 
most  important  results  to  illustrate  the  state  of  the 
knowledge  between  polyamines  and  cancer.    As 
mentioned  earlier,  transgenic  mice  overexpressing 
human ODC under its own promoter did not exhibit a 
higher  rate  of  spontaneous  tumorigenesis.  However, 
these mice more readily developed skin papillomas in 
response  to  a  two-stage  chemical  skin  tumorigenesis 
[52]. In contrast, overexpression of a truncated ODC in 
the  skin  caused  a  higher  level  of  spontaneous  skin 
tumor  development  [53].  However,  transgenic  mice 
overexpressing  a  dominant-negative  form  of  ODC  in 
the  skin  showed  similar  levels  of  tumor  development 
after induced skin tumorigenesis, casting doubts about 
the  involvement  of  ODC  in  tumorigenesis  [54].  A 
further  layer  of  complexity  was  added  using  SSAT 
overexpressing  mice,  which  developed  fewer 
papillomas in the two-stage skin tumorigenesis protocol 
[55]. When SSAT overexpression was directed to the 
hair follicle, transgenic animals were more prone to the 
two-stage  skin  tumorigenesis  [56].  Several  transgenic 
lines of mice overexpressing ODC antizyme in the skin 
have been shown to develop fewer papillomas in a two-
stage skin tumorigenesis [57]. Likewise, the incidence 
of  tumor  and  their  multiplicity  in  response  to  N-
nitrosomethylbenzylamine  in  the  fore-stomach  was 
decreased  in  transgenic  mice  overexpressing  ODC 
antizyme in the basal layer of cell of the fore-stomach 
epithelium [58]. 
 
Although the ability of polyamines to induce cancer is 
still a matter of debate, it is likely that their high levels 
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proliferative  capacity.  This  could  happen  by  the 
interaction of polyamines with oncogenes [reviewed in 
59].  Polyamines  have  thus  been  the  target  for 
chemotherapeutic agents for a relatively long time. Such 
potential  chemotherapeutic  drugs  developed  are 
polyamine synthesis inhibitors, polyamine analogues or 
polyamine-conjugated  compounds.  Many  reviews  and 
papers have gathered the knowledge on this field [3, 5, 
60-64].  The  ODC  inhibitor  DMFO  was  the  first  one 
synthesized  and  studied.  This  compound  showed  no 
effect  during  clinical  trials,  and  is  currently  being 
studied  as  a  chemopreventive  agent  rather  than  a 
chemotherapeutic  one  [reviewed  in  60].  Another 
approach is to target not polyamine metabolism itself, 
but  other  pathways  using  polyamines. 
Transglutaminases catalyze the incorporation of several 
low molecular weight amines into proteins. Polyamines 
are substrates for transglutaminases both in vitro and in 
vivo  [65].  Compounds  such  as  phytochemicals 
increased transglutaminase activity, and this correlated 
with less metastatic development of tumors [reviewed 
in  66].  Other  molecules  have  also  been  hinted  as 
potential  chemopreventive  agents.  Resveratrol  can 
inhibit  polyamine  synthesis  and  activate  polyamine 
catabolism [67]. It has been shown to reduce colitis and 
thus decrease colon cancer [68]. Ellagic acid depletes 
the polyamine pool and quercetin leads to inhibition of 
ODC expression and activity in cell lines [reviewed in 
69].  Interestingly,  some  of  these  compounds  increase 
life  span.  Resveratrol  can  increase  life  span  in 
invertebrate  model  organisms  although  contradictory 
results have been reported [70, 71, 72 versus 73] and it 
increases life span in mice on a high calorie diet [74] 
but not when normally fed [75, 76]. Resveratrol could 
trigger  its  beneficial  effects  by  modulating  S6  kinase 
activity [77, 78]. Quercetin has been reported to have 
anti-aging effects in cells [79] but no study in whole 
organism  has  been  carried  out.  Rapamycin  analogues 
are  currently  used  as  chemotherapeutics  [80]  and 
rapamycin  also  increases  life  span  in  several  model 
organisms, including rodents [76, 81-86]. 
 
Mechanisms of action of polyamines (Figure 3) 
 
Cell growth, apoptosis and necrosis 
 
Polyamines  are  essential  for  promoting  cell  growth. 
Polyamines could be part of a response of the cells to 
nutrient  availability,  especially  sugars,  that  would 
induce the cells to grow or not [87, 88]. They are also 
implicated in apoptosis but as often with polyamines, 
with contradictory results [reviewed in 89]. Polyamines 
increased  Ca
2+  accumulation  in  mitochondria, 
modulating  the  mitochondrial  permeability  transition, 
and triggering apoptosis [90]. Mitochondrial function is 
very important for life span regulation [91]. Spermine 
and  spermidine  interact  with  the  mitochondrial 
membrane  at  two  specific  binding  sites,  which  is  the 
first  step  of  their  transport  into  the  mitochondria. 
Polyamines  can  also  directly  promote  cytochrome  c 
release,  a  prelude  to  apoptosis  [92].  However,  the 
effects  of  polyamines  on  apoptosis  are  unclear.  High 
levels  of  polyamines  have  been  shown  to  trigger 
apoptosis in many cell types, but decreased levels can 
also  trigger  apoptosis.  Furthermore,  not  polyamines 
themselves  but  products  derived  from  polyamine 
metabolism may be responsible for apoptosis. Spermine 
decreased  the  mitochondrial  membrane  potential  and 
allowed  cytochrome  c  release  in  a  dose-dependent 
manner  in  cell  free  mitochondria  preparations  [93]. 
Spermidine  and  putrescine  both  also  induced 
uncoupling  and  cytochrome  c  release.  The  authors 
observed that H2O2 had the same effect and that catalase 
decreased  the  effects  of  polyamines  on  mitochondria. 
Based on these results, the authors suggested that the 
oxidation  products  of  polyamines,  not  polyamines 
themselves,  were  responsible  for  uncoupling  and 
cytochrome c release. Finally, polyamines can regulate 
the other type of cell death, necrosis. We observed that 
spermidine feeding increased yeast cells chronological 
life  span  by  reducing  necrotic  death  and  that  cells 
unable to synthesize polyamines exhibited higher levels 
of necrosis [4]. A recent report by Carmona-Gutierrez et 
al.  [94]  suggested  that  the  regulation  of  necrosis  by 
polyamines may work via cathepsin D (CatD). CatD has 
been involved in cancer cells proliferation and survival 
[95]. The overexpression of PEP4, the yeast ortholog of 
CatD,  increased  chronological  life  span  by  reducing 
necrosis.  This  anti-necrotic  effect  was  dependent  on 
putrescine  and  spermidine  synthesis,  but  not  on 
spermine synthesis. Furthermore, PEP4 overexpression 
prevented  the  age-related  decline  of  putrescine  and 
spermidine levels. 
 
Chromatin structure and gene regulation 
 
Due  to  their  cationic  nature,  polyamines  can  strongly 
bind  DNA  and  change  its  conformation.    Chromatin 
acetylation  plays  an  important  role  in  the  effect  of 
polyamines on DNA [reviewed in 96]. High polyamine 
levels  alter  histone  acetylation  and  histone  acetylases 
and  deacetylases  activities  in  proliferative  cells.  For 
instance,  in  keratinocytes  of  transgenic  mice 
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reduced  but  both  histone  acetylases  and  deacetylases 
activities were increased [97]. We have recently linked 
the  beneficial  effects  of  spermidine  on  life  span  and 
aging to acetylation [4]. Spermidine reduced acetylation 
at all studied lysine residues of histone H3 in yeast. We 
showed  that  the  premature  death  of  Δspe1  mutants 
unable  to  synthesize  polyamines  was  associated  with 
hyperacetylation. In contrast, double Δiki3/Δsas3 (both 
known to acetylate histone H3) mutants in yeast showed 
lower overall acetylation and as expected, were long-
lived,  produced  less  reactive  oxygen  species  and 
showed less necrosis. A screen for the loss of effect of 
spermidine  on  life  span  in  yeast  showed  that  the 
hypoacetylation  by  spermidine  was  mainly  due  to  an 
inhibition of histone acetylases rather than activation of 
histone  deacetylases.  Finally,  we  also  observed  lower 
acetylation  levels  in  peripheral  blood  mononuclear 
cells.  Taken  together,  the  results  showed  that 
polyamines affect acetylation, which in turn will affect 
gene  regulation.  Corroborating  this  idea,  Handa  and 
Mattoo [98] reported that high levels of spermidine and 
spermine  in  transgenic  tomato  fruit  up-regulated  the 
expression of a quarter out of 1066 studied genes and 
down-regulated half as many compared with wild-type 
fruits. They studied the effect of each polyamine on the 
level  of  10  chosen  proteins.  Putrescine  had  opposite 
effects  on  the  expression  of  these  proteins  from 
spermine and spermidine, resulting in opposite effects 
on  cellular  metabolism  in  ripening  fruits.  Spermidine 
also  regulates  gene  translation.  eIF5A  regulates 
translation  elongation  in  yeast,  Drosophila  and 
mammalian cells [99]. It is the only protein containing 
the  amino  acid  residue  hypusine.  eIF5A-hypusine  is 
specifically synthesized from spermidine by the enzyme 
deoxyhypusine hydroxylase via the formation of eIF5A-
deoxyhypusine  by  deoxyhypusine  synthase  (DHS, 
Figure 2). This reaction and the formation of eIF5A are 
important for cell growth as GC7, an inhibitor of DHS, 
inhibits cell proliferation. However, GC7 also leads to a 
reduction  of  polyamines,  which  could  lead  to  loss  of 
cell proliferation too. It was thought that hypusination 
may have been the major requirement of polyamines for 
cell proliferation. However, polyamines do not act on 
cell  growth  only  via  hypusination,  and  also  regulate 
translation  initiation  via  eIF2α  and  4E-BP.  In  fact, 
spermine was involved in the initiation of mitochondrial 
protein  synthesis  by  increasing  the  binding  of  fMet-
tRNA to the 28S small ribosomal subunit [100]. 
 
It  thus  seems  that  polyamines,  by  modulating 
acetylation  levels  and  protein  synthesis,  will  trigger 
varied  changes  that  can  potentially  lead  to  complex 
cellular responses. Such actions of polyamines may help 
explain how they can promote both cell growth and cell 
death  and  can  show  such  a  complex  involvement  in 
aging, stress and diseases. Finally, it has recently been 
reported that spermidine was also able to enhance the 
induced  reprogramming  of  SKOM  (Sox2,  Klf4,  Oct4 
and  c-Myc)-infected  primary  mouse  embryonic 
fibroblasts into pluripotent stem cells [101]. 
 
Autophagy 
 
 Autophagy  is  the  mechanism  responsible  for  the 
degradation  of  intracellular  macromolecules  and 
organelles.  Autophagy  is  an  essential  function  in 
development and survival as it will dispose of unwanted 
molecules  such  as  damaged  molecules  during  stress, 
aging or diseases, or during developmental remodeling. 
Autophagy  is  involved  in  many  diseases  [102-104]. 
Many genetic and non genetic manipulations increasing 
life span induce autophagy [105] and autophagy appears 
as  a  point  of  convergence  of  many  genetic  pathways 
involved in aging [106]. We have shown that induction 
of  autophagy  was  probably  the  main  mechanism  of 
action of spermidine to trigger its beneficial effects on 
life span and aging [4, 94, 107, 108]. First, we found 
that autophagy-related genes in yeast were up-regulated 
by spermidine addition. We also measured that the Atg7 
promoter  was  hyperacetylated  with  spermidine 
compared with the promoters of neighboring genes and 
despite the overall hypoacetylation effect of spermidine. 
We then confirmed that spermidine induced autophagy 
in  yeast,  worms,  flies  and  human  cells  by  direct 
measurements of autophagy levels. Finally, we showed 
that  life  extension  by  spermidine  was  abrogated  in 
yeast, worms and flies autophagy mutants. Morselli et 
al. [109] investigated by which mechanisms spermidine 
and  resveratrol  (both  increasing  life  span)  induced 
autophagy.  Both  compounds  induced  autophagy  in 
human colon cancer cells. However, decreased SIRT1 
activity  by  siRNA  or  SIRT1  inhibitor  abrogated 
resveratrol-induced  but  not  spermidine-induced 
autophagy  in  these  cells.  Spermidine  induced 
autophagy,  increased  survival  and  decreased  ROS 
production with age in both wild-type and Δsir2 mutant 
yeast.  In  worms,  spermidine-induced  autophagy  was 
slightly decreased in sir1.2 mutants but spermidine had 
the  same  effect  on  life  span  in  both  wild-type  and 
mutants. It appeared that the two compounds induced 
autophagy  by  distinct  pathways.  However,  they  both 
had  the  same  effect  on  protein  phosphorylation, 
suggesting  that  the  pathways  converge.  The  two 
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dependent  kinase/mTOR-independent  convergent 
pathways. The authors then studied the relation between 
acetylation and induction of autophagy. Spermidine and 
resveratrol induced acetylation changes in 375 proteins, 
170 of which belong to the human autophagy protein 
network.  They  found  that  in  the  cytoplasm,  the 
compounds induced more convergent deacetylation than 
acetylation. The reverse was observed in the nucleus. 
By using cytoplasts (enucleated cells), the authors could 
show  that  short-term  autophagy  was  regulated  by 
cytoplasmic  (de)acetylation  reactions.  These  results 
confirmed that autophagy is an important mechanism of 
action  of  spermidine.  It  would  be  now  interesting  to 
know  whether  the  other  polyamines  can  also  induce 
autophagy  and  study  further  the  relationship  between 
autophagy, aging, and diseases. 
 
Signaling pathways 
 
Polyamines  interact  with  signaling  pathways  to 
modulate  cellular  response.  CK2  is  a  kinase 
ubiquitously  expressed  with  important  roles  in  cell 
proliferation and survival [e.g., 110]. Stark et al. [111] 
investigated whether CK2 was a target of polyamines 
by  which  they  would  modulate  the  MAPK  pathway 
(Ras, Raf, MERK, Erk pathway). It had already been 
shown that polyamines regulate CK2 activity  in vitro 
[112]. By using Drosophila S2 cell cultures, Stark et al. 
[111] showed that CK2 formed a complex with KSR 
(kinase  suppressor  of  Ras)  and  phosphorylated  Draf. 
Spermine  decreased  Draf  phosphorylation  by  CK2  in 
vitro.  In  S2  cells,  spermine  decreased  Erk  activation 
(last step in the pathway) but putrescine and spermidine 
only  had  weak  effects.  In  contrast,  the  concomitant 
addition  of  putrescine  or  spermidine  increased  Erk 
activation. The authors suggested that CK2 could sense 
relative polyamine levels and translate the information 
to the MAPK pathway to trigger the appropriate cellular 
response. 
 
CONCLUSIONS AND PERSPECTIVES 
 
In  this  review,  we  have  seen  how  complex  the 
interaction of polyamines with aging and diseases is. So 
far, polyamines have been reported to be beneficial for 
aging.  They  can  increase  life  span  and  delay  kidney 
glomerular  atrophy.  The  various  studies  have  also 
shown mainly positive effects of polyamines on stress 
resistance. In plants, exogenous spermine treatment and 
increased polyamine synthesis by genetic means lead to 
higher  stress  resistance.  Spermidine  supplementation 
increases  stress  resistance  and  decreases  age-related 
oxidative  stress  markers  in  several  model  organisms. 
High  levels  of  polyamines  are  associated  with  many 
diseases, including cancers. In these cases, polyamines 
have  mostly  been  thought  of  as  exacerbating,  if  not 
causal,  factors.  However,  there  has  been  no  firm 
evidence that modulation of polyamine levels in itself 
can cause diseases, whether cancer or other age-related 
diseases  such  as  Parkinson’s  disease.  Furthermore, 
transgenic models with increased polyamine synthesis 
or catabolism have been shown to exhibit both higher 
and  lower  levels  of  tumorigenesis  after  chemically-
induced tumorigenesis protocols. Bringing together the 
results of the various fields of research on the effects 
and roles of polyamines has drawn a complex picture 
and  we  think  it  should  now  be  impossible  to  study 
polyamines in one field without taking into account the 
knowledge  gathered  in  the  others.  One  of  the  first 
complexities is that polyamines are usually taken as a 
family  of  similar  molecules.  However,  as  described, 
different polyamines can have different, even opposite 
effects. It is thus urgent to understand the role of each 
polyamine  as  well  as  of  their  combination  (a  natural 
occurrence in organisms) on aging and diseases. This is 
especially important for aging, as for the moment, only 
spermidine alone or a diet low or rich in polyamines in 
general have been studied for their effects on life span 
and aging. We also need to further our understanding of 
the  current  knowledge.  For  instance,  the  effect  of 
polyamines on life span and aging in rodents should be 
investigated as the first study showed promising, but so 
far  not  definitive  results.  Finally,  the  work  relating 
polyamines and aging have mainly focused on life span 
and the next step should investigate what are the effects 
of  polyamines  on  aging  and  whether  they  improve 
quality of life in older organisms. 
 
It  is  becoming  urgent  to  resolve  the  involvement  of 
polyamines in disease. The hypothesis that they could 
represent an early compensatory mechanism should be 
given attention. It is however an arduous task, as if this 
mechanism is efficient, the disease will not progress and 
the  effect  of  polyamines  will  thus  not  be  easily 
identifiable.  The  disease  may  be  seen  when  the 
compensatory  mechanism  has  failed  and  thus  the 
disease can progress, but the compensatory mechanism 
by  polyamines  is  maintained,  hence  the  apparent 
involvement of polyamines in the disease. 
 
Tools that could improve our understanding of the roles 
of polyamines are models exhibiting an accumulation of 
spermidine or spermine. To date, the transgenic models 
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accumulation  of  putrescine,  with  or  without  a 
concomitant  depletion  of  spermidine  and  spermine. 
Recently,  the  description  of  mice  overexpressing 
spermidine  synthase  was  reported  [113].  These  mice 
exhibited high levels of spermidine in heart, muscle and 
liver tissue. They were viable and fertile and it would be 
interesting now to use this new model in the study of 
the effect of spermidine on aging, stress and diseases. It 
is also important to understand the proximal effects on 
polyamine  metabolism  of  exogenous  addition  of  a 
single polyamine. For instance, we have observed that 
flies  fed  spermidine  exhibited  higher  levels  of 
spermidine,  but  also  of  putrescine  [4],  suggesting  an 
adaptation of polyamine metabolism to the influx of one 
polyamine. 
 
To  conclude,  our  understanding  of  the  role  of 
polyamines on aging and diseases has now reached a 
level  where  it  seems  that  polyamines  (particularly 
spermidine)  can  be  beneficial  for  aging  in  healthy 
organisms but that they may be harmful when disease 
appears.  So  far,  most  of  the  interventions  known  to 
beneficial  to  aging  (genetic  interventions,  dietary 
restriction,  rapamycin)  have  also  been  reported  to  be 
helpful against age-related diseases [see 114 and 115 for 
a discussion] and it would be an unusual characteristic 
of polyamines to exhibit such a dual effect on aging and 
diseases.  Bringing  together  the  various  fields  of 
research interested in the roles of polyamines will help 
us to further unravel the effects of polyamines to a point 
where the implementation of their use in humans would 
be the next step. 
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